ArticleBMC infectious diseases2025
Time series modelling and forecasting of mpox incidence and mortality in Nigeria.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Wavelet analysis and time series forecasting of malaria incidence across different transmission settings in Nigeria.BMC infectious diseases · 2026Article
- Modelling the association of rainfall and temperature with malaria incidence in Adamawa State, Nigeria.Scientific reports · 2026Article
- Article
- Predictive and interpretable machine learning for COVID-19 resurgences: the role of SARS-CoV-2 variants in the post-pandemic era.BMC infectious diseases · 2025Article
- Modeling COVID-19 response in Cuba: a hybrid approach combining agent-based modeling and time series analysis.Population health metrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization (WHO) declared mpox a Public Health Emergency of International Concern (PHEIC) twice, in response to the global outbreak, first in May 2022 and again in August 2024, after a span of 2 years and 3 months. African countries continue to be a hotspot for the ongoing mpox outbreaks and Nigeria has contributed substantially in exporting the virus to other countries, highlighting the need for an in-depth analysis of outbreak patterns and forecasting to inform public health policy. This study used the Auto-Regressive Integrated Moving Average (ARIMA) model to perform a 14-month forecast of mpox cases and mortality in Nigeria using mpox monthly routine data. The data were split into two portions; 70% for training, used to estimate the parameters of the forecasting model and 30% for testing, used to evaluate the model's accuracy. Wavelet analysis was used to decompose the time series into its various frequency components, enabling a multi-resolution analysis of the data. The ARIMA model forecasted an average of 13 mpox cases per month and zero mortality over a 14-month period. The wavelet power spectrum revealed a strong annual cycle between June 2022 and June 2023. In order to sustain the forecasted downward trend in mpox cases in the coming months, it is essential that the National Mpox Technical Working Group (TWG) of Nigeria Centre for Disease Control and Prevention (NCDC) continue to coordinate scale up of vaccine coverage and improve surveillance especially in high risk area. The findings will ultimately improve focused interventions and knowledge of mpox outbreak patterns by guiding public health policy, allocating resources optimally, and preparing health systems for potential outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.